Deutsche Bank Upgrades Health Management (HMA) to Buy; Recent Sell-Off = Opportunity

Deutsche Bank upgraded Health Management (NYSE: HMA) from Hold to Buy with a price target lowered $1 to $8.50.

Deutsche analyst says, "We consider the risk/reward on HMA shares to be tilted firmly to the upside in the wake of the recent sell-off. 3 key reasons: 2012 outlook is very do-able, refi positions balance sheet well, and CF is solid. While hospital sector fundamentals remain challenged and investigations remain an important risk factor here, we believe the opportunity in HMA shares presents well at 5.3x EBITDA. We've adjusted some ests in our 2012 model, bringing EBITDA (ex. HITECH) to $900M ($919M)."

For an analyst ratings summary and ratings history on Health Management click here. For more ratings news on Health Management click here.

Shares of Health Management closed at $5.92 yesterday.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Deutsche Bank Upgrades Huizhou Desay Sv Automotive Co (002920:CH) to Hold
• Deutsche Bank Upgrades Hilton Worldwide (HLT) to Buy
• Freedom Broker Upgrades Serve Robotics (SERV) to Buy